-
Loading metrics
Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencing
-
Vidya Balagopal,
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Writing – original draft, Writing – review & editing
Affiliation Department of Pathology, Division of Genomic and Molecular Pathology, The University of Chicago, Chicago, Illinois, United States of America
⨯ - Andrew Hantel,
- Sabah Kadri,
- George Steinhardt,
- Chao Jie Zhen,
- Wenjun Kang,
- Pankhuri Wanjari,
- Lauren L. Ritterhouse,
- Wendy Stock,
- Jeremy P. Segal
http://orcid.org/0000-0001-8630-7414
Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencing
- Vidya Balagopal,
- Andrew Hantel,
- Sabah Kadri,
- George Steinhardt,
- Chao Jie Zhen,
- Wenjun Kang,
- Pankhuri Wanjari,
- Lauren L. Ritterhouse,
- Wendy Stock,
- Jeremy P. Segal
x
- Published: October 28, 2019
- https://doi.org/10.1371/journal.pone.0224097